Title: Prevalence of “unexpected antibodies” in patients requiring blood transfusion at National Referral Hospital, Thimphu from 2015 to 2017: Retrospective study
Authors: Mahrukh Getshen, Tshering Yangdon, Lobzang Tashi, Dorji Wangchuk
DOI: https://dx.doi.org/10.18535/jmscr/v7i2.61
Abstract
Safe blood transfusion involves pre-transfusion compatibility testing including ABO and Rh typing, cross match testing and screening for unexpected antibodies. Unexpected antibodies are those other than naturally occurring (Hyung Joon Kim, 2013) anti-A and anti-B antibodies which can cause transfusion reactions such as acute or delayed hemolytic transfusion reaction. The aim of the study was to investigate the prevalence of unexpected antibodies in patient samples received by Blood Bank. A total of 39,655 antibody screening was performed from 2015-2017 using standard tube method with commercially available screen cells. The overall prevalence of alloantibodies were 0.39% with higher rate in females 76.5% than males (23.5%). Anti-Lea was the most commonly encountered alloantibodies (56.05%). Antibodies belonging to Rh system accounted for 11.47 % and remaining 24.2 % were undetected. Patients with unexpected alloantibodies may cause delayed transfusion reaction. Considering the delay in antibody testing and identification, it is vital to perform antibody screening for the donor units, so that the compatible blood unit will be accessible at times of need.
References
- HYUNG JOON KIM , YUN HEE LIM , BYUNG HOON YOO, SEUNG-HOON WOO, KI HYUK HONG, AND JUNG WON KIM, A detection of unexpected blood antibody at the time of transfusion was needed, during the operation -A case report. Korean J Anesthesiol 2013 January 64(1): 65-68. http://dx.doi.org/10.4097/kjae.2013.64.1.65
- HAN KS, PARK MH, KIM SI. Transfusion medicine. 3rd ed. Seoul, Korea Medical Publisher. 2006, pp 153-287
- KI-HO KO , BYUNG-HOON YOO , KYE-MIN KIM , WOO-YONG LEE , JUN-HEUM YON , KI-HYUK HONG , AND TAE-HEE HAN. Frequency of unexpected antibody and consideration during transfusion, Korean J Anesthesiol 2012 May 62(5): 412-417http://dx.doi.org/10.4097/kjae.2012.62.5.412
- SCHONEWILLE H.Red blood cell alloantibodies after transfusion.Leiden: University Press; 2008
- BRECHER ME. Technical manual.14th ed. Bethesda, Maryland: American Association of Blood Banks; 2002. pp. 315–397. (ME, 2002)
- HEDDLE NM, SOUTAR RL, O’HOSKI PL, SINGER J, MCBRIDE JA, ALI MA, ET AL. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000-5
- HOELTGE GA, DOMEN RE, RYBICKI LA, SCHAFFER PA. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med. 1995;119:42–5.
- KIM BS, KIM HO, SONG KS, LEE SY. Frequency of irregular antibodies detected by type and screen procedure. Korean J Blood Transfus 1990; 1: 47-50.
- HAN KS, CHO HI, KIM SI. A study on the hemolytic transfusion reactions due to irregular antibodies. Korean J Hematol 1989; 24: 27- 33.
- CHAUDHARY R, AGARWAL N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci.